Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.

Iemura, Tomoki; Itoh, Mitsuru; Mano, Chihiro; Oba, Akifumi; Kawabata, Norihiro; Horisawa, Yoshihito; Matsui, Masashi; Miyahara, Yasuko; Kanda, Junya

Iemura, Tomoki; Itoh, Mitsuru; Mano, Chihiro; Oba, Akifumi; Kawabata, Norihiro; Horisawa, Yoshihito; Matsui, Masashi; Miyahara, Yasuko; Kanda, Junya.

Afiliación

Iemura T; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Itoh M; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Mano C; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Oba A; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Kawabata N; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Horisawa Y; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Matsui M; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Miyahara Y; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
Kanda J; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Transfusion ; 58(12): 2773-2776, 2018 12.

Article en En | MEDLINE | ID: mdl-30265752

Asunto(s)

Trasplante de Células Madre de Sangre del Cordón Umbilical; Supervivencia de Injerto; Prueba de Histocompatibilidad; Isoanticuerpos; Mielofibrosis Primaria/sangre; Mielofibrosis Primaria/terapia; Adulto; Aloinjertos; Femenino; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Prueba de Histocompatibilidad / Trasplante de Células Madre de Sangre del Cordón Umbilical / Mielofibrosis Primaria / Supervivencia de Injerto / Isoanticuerpos Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Transfusion Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google